MedPath
HSA Approval

HALOXIN TABLET 100 mg

SIN11874P

HALOXIN TABLET 100 mg

HALOXIN TABLET 100 mg

April 12, 2002

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, SUGAR COATED

ORAL

Medical Information

P01BA02

hydroxychloroquine

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

HANLIM PHARMACEUTICAL CO LTD

Active Ingredients

HYDROXYCHLOROQUINE SULFATE

100 mg

Hydroxychloroquine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

HALOXIN TABLET 100 mg - HSA Approval | MedPath